Ireland
--:--IST
Latest
Clinical Trials in France / NCT04189965
Recruiting Not applicable

Traumatic Long-term Memory of Pain in Humans

NCT04189965 · tracked via the Priya Life Science France tracker
Phase
Not applicable
Started
2021-01-11
Last updated
2023-08-08

Condition(s) studied

PainTraumatic Memory

Investigational drug(s) / intervention(s)

Validation of virtual environment and auditive stimulation with virtual reality glasses (Pilot phase)Electrical cutaneous stimulation and auditive stimulation (Principal Experimental phase)Electrical cutaneous stimulation and auditive stimulation (Secondary Experimental phase)

Validation of virtual environment and auditive stimulation with virtual reality glasses (Pilot phase): The goal of this phase is the development of the experimental protocol in virtual reality. Virtual environment will be checked and auditive stimulation will be graduated.

Electrical cutaneous stimulation and auditive stimulation (Principal Experimental phase): This phase is the principal step of the study: during moving in virtual environment, electrical stimulation on one hand and auditive stimulation will be applied. EEG, ECG and skin conductance will be measured during conditioning phase and extinction phase (day 1, 30 minutes each phase). Behavioral measures will be done throughout the 3 sessions (day 1, day 2 and day 30)

Electrical cutaneous stimulation and auditive stimulation (Secondary Experimental phase): This phase is the same of the Principal Experimental phase except for the EEG that will not be performed.

Study summary

Few studies have focused on understanding the mechanisms underlying pain memory in humans. Thus, this project aims to investigate the link between pain memorisation and memorisation of the associated context by addressing the issue of pain conditioning. The study is composed of two successive parts: one pilot then one experimental. The goal is to understand pain memorisation processes by analysing the parallel between pain memorisation and memorisation of a traumatic event. By using immersive virtual reality, investigators aim to show that contextual pain conditioning is associated with : 1- a specific neural networks; 2- a reactivation of vegetative and behavioural reactions related to pain as well as electro-physiological markers when re-exposure to the specific pain-conditioning-context; 3- an implicit hypermnesia of the pain-associated context and a struggle to extinguish conditioning; 4- a favoured elaboration of false memories of the contextual pain. The emitted hypothesis suggests that a cortical and behavioural mnemonic trace is created during encoding of pain in association with its context, and that the latter can reactivate although the pain itself has disappeared. This implicit cortical mnemonic trace, evoked by the simple pain-associated context, could explain the notion of pain print persisting at long-term in patients suffering from chronic pain.

Eligibility

Sex
ALL
Min age
18 Years
Max age
50 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Healthy subject * Subject between 18 and 50 years old * Subjects having given their written consent * Subjects with health insurance Exclusion Criteria: * Prior addiction to drugs * Prior neurological issues * Chronic pain (neuropathic or non-neuropathic) * Pregnant/breast-feeding women * Absence of efficient contraception method for the duration of the study (1 month) for participants of procreation age (no inclusion limitation for male participants of procreation age) * Subjects under chronic analgesic treatment or having taken an analgesic treatment in the 24 h preceding the experiment * Heart issues * Subjects under justice surveillance * Subjects participating in another study which inclusion period overlaps with the one from this study

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Hôpital Neurologique, Bron France Recruiting

More Hospices Civils de Lyon trials in France

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT04189965 on ClinicalTrials.gov ↗ ← All trials in France